Sentence: Finally , a further synergistically improved myeloma cell lysis with the daratumumab-IPH2102 combination was observed by adding lenalidomide , which suggests that more effective treatment strategies can be designed for multiple myeloma by combining daratumumab with agents that independently modulate natural killer cell function .
Drug combination annotation:
[{'class': 'POS', 'spans': ['lenalidomide', 'daratumumab'], 'is_context_needed': False}]